Montara Therapeutics

San Francisco, CA · Founded 2023 · Privately Held (backing)

Operator of a biopharmaceutical company intended to enhance the safety and efficacy of treatments for neurological diseases. Montara Therapeutics is based in San Francisco, CA and was founded in 2023. It was valued at $55 million at its seed round in Feb 2025, the last priced event on record. It has raised $28 million across 2 recorded rounds; the latest was a $20 million early-stage round in Feb 2025.

PMV mark · valuation
$55.0M
Oct 2026
Priced at
its seed round
Feb 2025
Total raised
$28.0M
Last round
Early Stage VC
Feb 2025
What is Montara Therapeutics worth?
$55.0MPrivateMarketView mark · Oct 2026

Valued at $55.0M at its seed round, Feb 2025. Nothing has traded since.

Free account
More of Montara Therapeutics with a free account
  • ·Watch Montara Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Montara Therapeutics funding history

2 rounds
DateRoundRaisedPost-money
Feb 2025Early Stage VC$20.0M▮
Jan 2024Early Stage VC$8.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Montara Therapeutics valuation

Montara Therapeutics was valued at $55 million at its seed round in Feb 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Montara Therapeutics raised?

Montara Therapeutics has raised $28 million across 2 recorded rounds since 2024. The largest was an $8 million early-stage round in Jan 2024; the most recent was a $20 million early-stage round in Feb 2025.

Montara Therapeutics has filed 2 Form Ds with the SEC since 2024, most recently in Mar 2025 ($20 million sold to 9 investors).

How Montara Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Montara Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Montara Therapeutics

What is Montara Therapeutics worth?
Montara Therapeutics is valued at $55.0M as of Oct 2026. Valued at $55.0M at its seed round, Feb 2025. Nothing has traded since.
How much has Montara Therapeutics raised?
Montara Therapeutics has raised $28.0M in total funding across 2 recorded rounds.
When did Montara Therapeutics last raise?
Montara Therapeutics last raised in Feb 2025 (Early Stage VC), raising $20.0M.